Chronic inflammation leaves long-lasting impression on gut stem cells, increasing colorectal cancer risk
Clinical Scorecard: Persistent Inflammation Alters Gut Stem Cell Function, Elevating Colorectal Cancer Risk
At a Glance
| Category | Detail |
|---|
| Condition | Colorectal Cancer Risk due to Chronic Inflammation |
| Key Mechanisms | Alterations in gut stem cells and increased activity of AP-1 transcription factors |
| Target Population | Individuals with a history of chronic colitis |
| Care Setting | Oncology and Gastroenterology |
Key Highlights
- Chronic gut inflammation can lead to heritable changes in stem cells.
- AP-1 transcription factors are linked to increased tumor growth post-colitis.
- Epigenetic memories of inflammation persist for over 100 days.
- Blocking AP-1 activity can mitigate pro-cancer effects of colitis.
- Potential for early evaluation and therapeutic interventions based on epigenetic changes.
Guideline-Based Recommendations
Diagnosis
- Monitor patients with chronic colitis for signs of colorectal cancer.
Management
- Consider therapies targeting AP-1 activity in patients with a history of colitis.
Monitoring & Follow-up
- Evaluate epigenetic changes in patients recovering from chronic inflammation.
Risks
- Increased risk of colorectal cancer following chronic gut inflammation.
Patient & Prescribing Data
Patients with chronic colitis or inflammatory bowel disease.
Potential for new therapeutics aimed at disrupting post-colitis cellular changes.
Clinical Best Practices
- Regular screening for colorectal cancer in patients with chronic inflammation.
- Research into epigenetic markers as predictive tools for cancer risk.
References
